Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Phase 3 Randomized Controlled Study of Renal Autologous Cell Therapy (REACT) in Subjects With Type 2 Diabetes and Chronic Kidney Disease (REGEN-006)
Sponsored by IQVIA RDS Inc.
Active
$770.6K Funding
3 People
External
Related Topics
cell therapy,
diabetes,
chronic kidney disease,
clinical trial,
renal therapy
People
Gregory Woodhead
Co-Investigator (COI)
Medical Imaging
﹒Assistant Professor
Stephanie Soto
(CD)
Cancer Center Division
﹒Clinical Research Coordinator III
Katherine Mendoza
(CD)
Epidemiology and Biostatistics
﹒Research Manager II
